| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |